Cannasoul Group

Cannasoul is Israel’s leading analytical service provider. Utilizing its proprietary know-how and expertise, Cannasoul has become a top-tier expert in the field of analytical method development for pharma and botanical R&D providing the necessary and crucial information to meet the standards for the development of effective, safe, and reliable products, treatments, and pharmaceuticals. Cannasoul also holds a unique expertise in the field of Cannabis and Psilocybin research and is the first company in the world to analyze over 100 cannabinoids and 100 terpenes. In addition to the comprehensive phytocannabinoid and terpene analysis, Cannasoul offers a unique and comprehensive endocannabinoid analysis in a wide range of matrixes. Cannasoul is a scientific partner to leading research organizations and pharmaceutical companies and supports them with R&D activities, pre-clinical and clinical trials, including pharmacokinetic studies (PK) and other bio-analytics.